Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/12/1998 | US5750376 In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
05/12/1998 | US5750374 Process for producing hydrophobic polypeptides and proteins, and fusion proteins for use in producing same |
05/12/1998 | US5750373 Fusing gene coding a protein of interest to carboxy terminal domain of the gene coat protein of the filamentous phage m13, mutating |
05/12/1998 | US5750372 Vector having promoter that is inducible by methanol and/or glycerol |
05/12/1998 | US5750371 Water-soluble mutein of FGF receptor, DNA and production thereof |
05/12/1998 | US5750370 Genetic engineering |
05/12/1998 | US5750369 DNA encoding a prostaglandin F28 receptor, a host cell transformed therewith and an expression product thereof |
05/12/1998 | US5750368 Culturing an acetic acid-resistant escherichia mutant having been transformed by a recombinant plasmid-carrying gene for producing the desired substance, e.g. enzymes, motilins, polypeptide hormones, biotin, fad or carotenoids |
05/12/1998 | US5750367 Cardiovascular |
05/12/1998 | US5750366 Cloning and expression of gonadotropin-releasing hormone receptor |
05/12/1998 | US5750365 Isolated nucleic acid encoding a newt acidic fibroblast growth factor (AFGF) |
05/12/1998 | US5750362 Methods for identifying substances with a potential herbicidal or growth-regulating action by means of plant transporter proteins, the use of the transporter proteins, and substances with a herbicidal and growth-regulating action |
05/12/1998 | US5750361 Formation and use of prion protein (PRP) complexes |
05/12/1998 | US5750350 Kit containing antibodies |
05/12/1998 | US5750346 Cloning |
05/12/1998 | US5750345 Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders |
05/12/1998 | US5750344 Method for selection of biologically active peptide sequences |
05/12/1998 | US5750342 Contacting mixture of nucleic acids with target comprising blood cells, fibrin clots, carotid arteries, partitioning high affinity nucleic acids from remainder of mixture, amplifying to yield mixture enriched in high affinity nucleic acids |
05/12/1998 | US5750337 Internal reflection fluorescence |
05/12/1998 | US5750334 Detection of human papillomavirus mRNA in cervical smears |
05/12/1998 | US5750331 Detection of antibodies for hepatitis c with proteins |
05/12/1998 | US5750176 Transgenic non-human mammal milk comprising 2'-fucosyl-lactose |
05/12/1998 | US5750172 Transgenic non human mammal milk |
05/12/1998 | US5750114 Glycosylated glycoprotein d polypeptide |
05/12/1998 | US5750110 Vaccine composition containing adjuvants |
05/12/1998 | US5750078 Side effect reduction |
05/12/1998 | US5749847 Delivery of nucleotides into organisms by electroporation |
05/12/1998 | US5749319 Pearl and method for producing same |
05/12/1998 | US5749169 Identification and selection of androgenetic haploids |
05/07/1998 | WO1998019271A1 Proteome analysis for characterization of up- and down-regulated proteins in biological samples |
05/07/1998 | WO1998018963A1 Chromosomal markers and diagnostic tests for manic-depressive illness |
05/07/1998 | WO1998018961A1 Methods for preparing arrays of single-stranded dna |
05/07/1998 | WO1998018960A1 Process aimed at evidencing the state of a malignant cell and process for treatment |
05/07/1998 | WO1998018959A1 Method for diagnosis of genetic diseases by molecular combing and diagnosis box |
05/07/1998 | WO1998018954A1 Process and composition for preparing d-aspartic acid |
05/07/1998 | WO1998018951A1 Receptor-mediated gene transfer system for targeting tumor gene therapy |
05/07/1998 | WO1998018950A2 Aav-dna helper virus sequences |
05/07/1998 | WO1998018949A2 Plant cellulose synthase and promoter sequences |
05/07/1998 | WO1998018948A1 Flax promoters for manipulating gene expression |
05/07/1998 | WO1998018947A1 Methods for the characterization and selection of rna target motifs that bind compounds of pharmaceutical use |
05/07/1998 | WO1998018946A1 Process for bacterial production of polypeptides |
05/07/1998 | WO1998018945A1 Reagents and methods useful for detecting diseases of the breast |
05/07/1998 | WO1998018943A1 Method for the oligomerisation of peptides |
05/07/1998 | WO1998018942A2 Novel human rab proteins |
05/07/1998 | WO1998018941A1 Method for preparing 2-hydroxy 4-methylthio butyric acid using a nitrilase |
05/07/1998 | WO1998018940A1 Leaf-specific gene expression in transgenetic plants |
05/07/1998 | WO1998018939A1 Novel salicylic acid induced map kinase and its use for enhanced disease resistance in plants |
05/07/1998 | WO1998018938A1 Novel human spermidine/spermine n1-acetyltransferase |
05/07/1998 | WO1998018937A1 Microbial preparation of substances from aromatic metabolism/ii |
05/07/1998 | WO1998018936A1 Microbial preparation of substances from aromatic metabolism/i |
05/07/1998 | WO1998018935A2 P70-s6k or related kinase with constitutive activity |
05/07/1998 | WO1998018934A1 Therapeutic gene |
05/07/1998 | WO1998018933A1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
05/07/1998 | WO1998018932A2 Novel pesticidal toxins and nucleotide sequences which encode these toxins |
05/07/1998 | WO1998018931A2 Streptococcus pneumoniae polynucleotides and sequences |
05/07/1998 | WO1998018930A2 Streptococcus pneumoniae antigens and vaccines |
05/07/1998 | WO1998018929A1 Nucleic acid sequences encoding citrate transporter proteins |
05/07/1998 | WO1998018928A1 Immunogenic detoxified mutant e. coli lt-a toxin |
05/07/1998 | WO1998018927A1 Candida albicans proteins associated with virulence and hyphal formation and uses thereof |
05/07/1998 | WO1998018926A1 Circularly permuted erythropoietin receptor agonists |
05/07/1998 | WO1998018925A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids |
05/07/1998 | WO1998018924A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
05/07/1998 | WO1998018923A1 NOVEL flt-3 RECEPTOR AGONISTS |
05/07/1998 | WO1998018922A1 Human phosphoprotein |
05/07/1998 | WO1998018921A1 NEUTROKINE $g(a) |
05/07/1998 | WO1998018920A1 cDNA FRAGMENTS OF GENE CAUSATIVE OF SPINOCEREBELLAR ATAXIA TYPE 2 |
05/07/1998 | WO1998018919A2 Gabaa receptor subunit epsilon-related protein |
05/07/1998 | WO1998018918A1 Stable expression of triple helical proteins |
05/07/1998 | WO1998018917A2 RIBOFLAVIN MUTANTS AS VACCINES AGAINST $i(ACTINOBACILLUS PLEUROPNEUMONIAE) |
05/07/1998 | WO1998018916A1 Human p2x purinoreceptor |
05/07/1998 | WO1998018915A2 Method for selective and irreversible cross-linking of platinized oiligonucleotides on rna and its applications |
05/07/1998 | WO1998018913A1 High level of expression of ingap |
05/07/1998 | WO1998018912A1 Novel phospholipase, production and use thereof |
05/07/1998 | WO1998018910A1 Nucleic acid sequence encoding beta-c-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin |
05/07/1998 | WO1998018909A1 Enzymatic cofactor cycling using soluble pyridine nucleotide transhydrogenase |
05/07/1998 | WO1998018905A1 Extracellular expression of cellulose binding domains (cbd) using bacillus |
05/07/1998 | WO1998018825A1 Anti-p53 single-chain antibody fragments and their uses |
05/07/1998 | WO1998018824A1 Human tumor necrosis factor receptor-like 2 |
05/07/1998 | WO1998018812A1 Oligomers which inhibit the expression of interleukin genes |
05/07/1998 | WO1998018811A1 Delivery construct for antisense nucleic acids and methods of use |
05/07/1998 | WO1998018810A1 Immunostimulatory nucleic acid molecules |
05/07/1998 | WO1998018809A1 Targeted cytolysis of cancer cells |
05/07/1998 | WO1998018483A1 Oncostatin m for treating inflammation |
05/07/1998 | WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
05/07/1998 | WO1998018456A1 Protease-activated receptor 3 and uses thereof |
05/07/1998 | WO1998018324A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna |
05/07/1998 | WO1998018323A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
05/07/1998 | WO1998012311A3 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
05/07/1998 | WO1998011243A3 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
05/07/1998 | WO1998011226A3 Mammalian chemokines, related reagents |
05/07/1998 | WO1998010069A3 E25a protein, methods for production and use thereof |
05/07/1998 | WO1998008965A3 Cd95 regulatory gene sequences and transcription factors |
05/07/1998 | WO1998008856A3 Mirror-symmetrical selection and evolution of nucleic acids |
05/07/1998 | WO1998007855A3 Secreted proteins and polynucleotides encoding them |
05/07/1998 | WO1998007415A3 Methods for prevention of cellular proliferation and restenosis |
05/07/1998 | WO1998006851A3 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF $i(MORAXELLA CATARRHALIS) |
05/07/1998 | WO1998006841A3 Two human nsp-like proteins |
05/07/1998 | WO1998006747A3 Uses for wnt polypeptides |
05/07/1998 | WO1998006248A3 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
05/07/1998 | WO1998000538A3 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |